BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 20599798)

  • 1. Temperature dependent photolabeling of the human angiotensin II type 1 receptor reveals insights into its conformational landscape and its activation mechanism.
    Arsenault J; Cabana J; Fillion D; Leduc R; Guillemette G; Lavigne P; Escher E
    Biochem Pharmacol; 2010 Oct; 80(7):990-9. PubMed ID: 20599798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temperature-dependent variations of ligand-receptor contact points in hAT(1).
    Arsenault J; Renaud MP; Clément M; Fillion D; Guillemette G; Leduc R; Lavigne P; Escher E
    J Pept Sci; 2007 Sep; 13(9):575-80. PubMed ID: 17600857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residues 293 and 294 are ligand contact points of the human angiotensin type 1 receptor.
    Pérodin J; Deraët M; Auger-Messier M; Boucard AA; Rihakova L; Beaulieu ME; Lavigne P; Parent JL; Guillemette G; Leduc R; Escher E
    Biochemistry; 2002 Dec; 41(48):14348-56. PubMed ID: 12450401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation induces structural changes in the liganded angiotensin II type 1 receptor.
    Clément M; Cabana J; Holleran BJ; Leduc R; Guillemette G; Lavigne P; Escher E
    J Biol Chem; 2009 Sep; 284(39):26603-12. PubMed ID: 19635801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The amino-terminus of angiotensin II contacts several ectodomains of the angiotensin II receptor AT1.
    Fillion D; Lemieux G; Basambombo LL; Lavigne P; Guillemette G; Leduc R; Escher E
    J Med Chem; 2010 Mar; 53(5):2063-75. PubMed ID: 20146480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereospecific synthesis of a carbene-generating angiotensin II analogue for comparative photoaffinity labeling: improved incorporation and absence of methionine selectivity.
    Fillion D; Deraët M; Holleran BJ; Escher E
    J Med Chem; 2006 Apr; 49(7):2200-9. PubMed ID: 16570916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methionine proximity assay, a novel method for exploring peptide ligand-receptor interaction.
    Rihakova L; Deraët M; Auger-Messier M; Pérodin J; Boucard AA; Guillemette G; Leduc R; Lavigne P; Escher E
    J Recept Signal Transduct Res; 2002; 22(1-4):297-313. PubMed ID: 12503623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photolabeling identifies position 172 of the human AT(1) receptor as a ligand contact point: receptor-bound angiotensin II adopts an extended structure.
    Boucard AA; Wilkes BC; Laporte SA; Escher E; Guillemette G; Leduc R
    Biochemistry; 2000 Aug; 39(32):9662-70. PubMed ID: 10933782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of constitutive activity: mutations at position 111 of the angiotensin AT1 receptor.
    Nikiforovich GV; Mihalik B; Catt KJ; Marshall GR
    J Pept Res; 2005 Nov; 66(5):236-48. PubMed ID: 16218991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining the environment of the ligand binding pocket of the human angiotensin II type I (hAT1) receptor using the methionine proximity assay.
    Clément M; Martin SS; Beaulieu ME; Chamberland C; Lavigne P; Leduc R; Guillemette G; Escher E
    J Biol Chem; 2005 Jul; 280(29):27121-9. PubMed ID: 15890659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenesis of the AT1 receptor reveals different binding modes of angiotensin II and [Sar1]-angiotensin II.
    Santos EL; Pesquero JB; Oliveira L; Paiva AC; Costa-Neto CM
    Regul Pept; 2004 Jul; 119(3):183-8. PubMed ID: 15120479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The active and the inactive form of the hAT1 receptor have an identical ligand-binding environment: an MPA study on a constitutively active angiotensin II receptor mutant.
    Clément M; Chamberland C; Pérodin J; Leduc R; Guillemette G; Escher E
    J Recept Signal Transduct Res; 2006; 26(5-6):417-33. PubMed ID: 17118790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of peptide contact points in the human angiotensin II type I receptor (AT1) with photosensitive analogs of angiotensin II.
    Laporte SA; Boucard AA; Servant G; Guillemette G; Leduc R; Escher E
    Mol Endocrinol; 1999 Apr; 13(4):578-86. PubMed ID: 10194764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential docking of high-affinity peptide ligands to type A and B cholecystokinin receptors demonstrated by photoaffinity labeling.
    Dong M; Liu G; Pinon DI; Miller LJ
    Biochemistry; 2005 May; 44(17):6693-700. PubMed ID: 15850403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photolabeling study of the ligand binding domain of natriuretic peptide receptor A: development of a model.
    Jossart C; Coupal M; McNicoll N; Fournier A; Wilkes BC; De Léan A
    Biochemistry; 2005 Feb; 44(7):2397-408. PubMed ID: 15709752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photolabelling the urotensin II receptor reveals distinct agonist- and partial-agonist-binding sites.
    Holleran BJ; Beaulieu ME; Proulx CD; Lavigne P; Escher E; Leduc R
    Biochem J; 2007 Feb; 402(1):51-61. PubMed ID: 17064254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct binding mode of 125I-AngII to AT1 receptor without the Cys18-Cys274 disulfide bridge.
    Martin RP; Rodrigues ES; Pacheco NA; Corrêa SA; Oliveira SM; Oliveira L; Nakaie CR; Shimuta SI
    Regul Pept; 2009 Nov; 158(1-3):14-8. PubMed ID: 19651161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site.
    Ploug M
    Biochemistry; 1998 Nov; 37(47):16494-505. PubMed ID: 9843416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the angiotensin II type 1 receptor leads to movement of the sixth transmembrane domain: analysis by the substituted cysteine accessibility method.
    Martin SS; Holleran BJ; Escher E; Guillemette G; Leduc R
    Mol Pharmacol; 2007 Jul; 72(1):182-90. PubMed ID: 17446269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for transmembrane domains V and VI in ligand binding and maturation of the angiotensin II AT1 receptor.
    Pignatari GC; Rozenfeld R; Ferro ES; Oliveira L; Paiva AC; Devi LA
    Biol Chem; 2006 Mar; 387(3):269-76. PubMed ID: 16542148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.